Johnson & Johnson closed $25.19 below its 52-week high ($168.85), which the company reached on September 4th.

Johnson & Johnson says its bispecific antibody, paired with a Janssen drug, could change treatment for non-small lung cancer ...

Valued at a market cap of $348.2 billion, Johnson & Johnson (JNJ) researches, develops, manufactures, and sells various ...

Republican Mike Johnson won reelection to the House speakership on a first ballot, pushing past GOP hard-right holdouts and ...